[English] 日本語
Yorodumi- PDB-3fqw: Phosphorylation of self-peptides alters Human Leukocyte Antigen C... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 3fqw | ||||||
|---|---|---|---|---|---|---|---|
| Title | Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes | ||||||
Components |
| ||||||
Keywords | IMMUNE SYSTEM / PHOSPHORYLATION / Glycoprotein / Immune response / Membrane / MHC I / Phosphoprotein / Polymorphism / Transmembrane / Ubl conjugation / Disease mutation / Immunoglobulin domain / Pyrrolidone carboxylic acid / Secreted / cancer / TCR / self-epitope | ||||||
| Function / homology | Function and homology informationpositive regulation of type B pancreatic cell proliferation / epithelial cell migration / negative regulation of long-chain fatty acid import across plasma membrane / IRS-related events triggered by IGF1R / positive regulation of glucose metabolic process / positive regulation of fatty acid beta-oxidation / cellular response to peptide / IRS-mediated signalling / Signaling by Erythropoietin / phosphatidylinositol 3-kinase activator activity ...positive regulation of type B pancreatic cell proliferation / epithelial cell migration / negative regulation of long-chain fatty acid import across plasma membrane / IRS-related events triggered by IGF1R / positive regulation of glucose metabolic process / positive regulation of fatty acid beta-oxidation / cellular response to peptide / IRS-mediated signalling / Signaling by Erythropoietin / phosphatidylinositol 3-kinase activator activity / Erythropoietin activates STAT5 / Erythropoietin activates Phospholipase C gamma (PLCG) / type B pancreatic cell proliferation / transmembrane receptor protein tyrosine kinase adaptor activity / mammary gland development / Signaling by Leptin / PI3K/AKT activation / positive regulation of mesenchymal cell proliferation / positive regulation of memory T cell activation / T cell mediated cytotoxicity directed against tumor cell target / TAP complex binding / Golgi medial cisterna / negative regulation of B cell apoptotic process / positive regulation of CD8-positive, alpha-beta T cell activation / CD8-positive, alpha-beta T cell activation / positive regulation of CD8-positive, alpha-beta T cell proliferation / Erythropoietin activates Phosphoinositide-3-kinase (PI3K) / IRS activation / CD8 receptor binding / antigen processing and presentation of exogenous peptide antigen via MHC class I / beta-2-microglobulin binding / lipid homeostasis / endoplasmic reticulum exit site / TAP binding / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent / regulation of lipid metabolic process / RET signaling / protection from natural killer cell mediated cytotoxicity / PI3K Cascade / positive regulation of epithelial cell migration / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent / SOS-mediated signalling / antigen processing and presentation of endogenous peptide antigen via MHC class Ib / positive regulation of glycogen biosynthetic process / Signal attenuation / response to glucose / detection of bacterium / Growth hormone receptor signaling / T cell receptor binding / Erythropoietin activates RAS / phosphatidylinositol 3-kinase binding / positive regulation of B cell proliferation / 14-3-3 protein binding / signaling adaptor activity / Interleukin-7 signaling / insulin-like growth factor receptor signaling pathway / negative regulation of receptor binding / early endosome lumen / Nef mediated downregulation of MHC class I complex cell surface expression / DAP12 interactions / transferrin transport / cellular response to iron ion / positive regulation of D-glucose import / lumenal side of endoplasmic reticulum membrane / Endosomal/Vacuolar pathway / insulin receptor binding / Antigen Presentation: Folding, assembly and peptide loading of class I MHC / peptide antigen assembly with MHC class II protein complex / cellular response to glucose stimulus / cellular response to iron(III) ion / MHC class II protein complex / negative regulation of forebrain neuron differentiation / antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent / ER to Golgi transport vesicle membrane / peptide antigen assembly with MHC class I protein complex / regulation of iron ion transport / regulation of erythrocyte differentiation / HFE-transferrin receptor complex / response to molecule of bacterial origin / MHC class I peptide loading complex / T cell mediated cytotoxicity / positive regulation of T cell cytokine production / antigen processing and presentation of endogenous peptide antigen via MHC class I / positive regulation of insulin secretion / brain development / antigen processing and presentation of exogenous peptide antigen via MHC class II / positive regulation of immune response / MHC class I protein complex / positive regulation of T cell activation / peptide antigen binding / positive regulation of receptor-mediated endocytosis / negative regulation of neurogenesis / cellular response to nicotine / positive regulation of T cell mediated cytotoxicity / multicellular organismal-level iron ion homeostasis / specific granule lumen / positive regulation of type II interferon production / glucose metabolic process / phagocytic vesicle membrane / recycling endosome membrane Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / MOLECULAR REPLACEMENT / Resolution: 1.927 Å | ||||||
Authors | Petersen, J. / Rossjohn, J. | ||||||
Citation | Journal: Proc.Natl.Acad.Sci.Usa / Year: 2009Title: Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes Authors: Petersen, J. / Wurzbacher, S.J. / Williamson, N.A. / Ramarathinam, S.H. / Reid, H.H. / Nair, A.K. / Zhao, A.Y. / Nastovska, R. / Rudge, G. / Rossjohn, J. / Purcell, A.W. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 3fqw.cif.gz | 177.9 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb3fqw.ent.gz | 140.2 KB | Display | PDB format |
| PDBx/mmJSON format | 3fqw.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 3fqw_validation.pdf.gz | 433 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 3fqw_full_validation.pdf.gz | 434.1 KB | Display | |
| Data in XML | 3fqw_validation.xml.gz | 19.1 KB | Display | |
| Data in CIF | 3fqw_validation.cif.gz | 28.2 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/fq/3fqw ftp://data.pdbj.org/pub/pdb/validation_reports/fq/3fqw | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 3fqnC ![]() 3fqrC ![]() 3fqtC ![]() 3fquC ![]() 3fqxC ![]() 2vllS C: citing same article ( S: Starting model for refinement |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
-Protein , 2 types, 2 molecules AB
| #1: Protein | Mass: 31854.203 Da / Num. of mol.: 1 Fragment: EXTRACELLULAR DOMAINS ALPHA1, ALPHA2, ALPHA3, UNP residues 25-299 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: HLA-A, HLAA / Plasmid: pET 30 / Production host: ![]() |
|---|---|
| #2: Protein | Mass: 11635.002 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: B2M / Plasmid: pET 30 / Production host: ![]() |
-Protein/peptide , 1 types, 1 molecules C
| #3: Protein/peptide | Mass: 873.974 Da / Num. of mol.: 1 / Source method: obtained synthetically / Details: synthetic peptide / References: UniProt: Q9Y4H2*PLUS |
|---|
-Non-polymers , 3 types, 343 molecules 




| #4: Chemical | ChemComp-CD / #5: Chemical | ChemComp-CO / | #6: Water | ChemComp-HOH / | |
|---|
-Details
| Has protein modification | Y |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.99 Å3/Da / Density % sol: 58.81 % / Mosaicity: 0.456 ° |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, hanging drop / pH: 7.4 Details: 13% PEG3350, 10mM CdCl2, 10mM CoCl2, 0.1M NaCl, pH7.4, temperature 293K, VAPOR DIFFUSION, HANGING DROP |
-Data collection
| Diffraction | Mean temperature: 100 K |
|---|---|
| Diffraction source | Source: ROTATING ANODE / Type: RIGAKU RUH3R / Wavelength: 1.5418 Å |
| Detector | Type: RIGAKU RAXIS IV++ / Detector: IMAGE PLATE / Date: May 8, 2008 / Details: osmic mirrors |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.5418 Å / Relative weight: 1 |
| Reflection | Resolution: 1.927→50 Å / Num. obs: 38037 / % possible obs: 93.1 % / Redundancy: 4.7 % / Rmerge(I) obs: 0.056 / Χ2: 1.014 / Net I/σ(I): 22.144 |
| Reflection shell | Resolution: 1.93→2 Å / Redundancy: 3.9 % / Rmerge(I) obs: 0.328 / Mean I/σ(I) obs: 3.7 / Num. unique all: 3049 / Χ2: 0.992 / % possible all: 75.9 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: PDB ENTRY 2VLL Resolution: 1.927→23.655 Å / Occupancy max: 1 / Occupancy min: 0.5 / FOM work R set: 0.873 / SU ML: 0.23 / Cross valid method: THROUGHOUT / σ(F): 1.34
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL / Bsol: 42.378 Å2 / ksol: 0.363 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 74.93 Å2 / Biso mean: 28.227 Å2 / Biso min: 8.11 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.927→23.655 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Total num. of bins used: 13
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Citation

























PDBj


















